Commission Decision of 30 November 2010 approving certain amended programmes for the eradication and monitoring of animal diseases and zoonoses for the year 2010 and amending Decision 2009/883/EC as regards the financial contribution by the Union for programmes approved by that Decision (notified under document C(2010) 8290) (2010/732/EU)

In forceVersion 2010-11-30from 2010-12-01

Grade B

mapped from publisher markup. A grade says how a document's structure was obtained, not how reliable the law is.

Ask Gelex about this law

Address https://gelex.eu/eli/EU/decision/2010/732@2010-11-30/en

Contents

Preamble

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Council Decision 2009/470/EC of 25 May 2009 on expenditure in the veterinary field, and in particular Article 27(5) and (6) thereof,

Whereas:

(1) Decision 2009/470/EC lays down the procedures governing the financial contribution by the Union for programmes for the eradication, control and monitoring of animal diseases and zoonoses.

(2) Commission Decision 2008/341/EC of 25 April 2008 laying down Community criteria for national programmes for the eradication, control and monitoring of certain animal diseases and zoonoses provides that in order to be approved under the measures provided for in Article 27(1) of Decision 2009/470/EC, programmes submitted by the Member States to the Commission for the eradication, control and monitoring of the animal diseases and zoonoses listed in the Annex to that Decision must meet at least the criteria set out in the Annex to Decision 2008/341/EC.

(3) Commission Decision 2009/883/EC of 26 November 2009 approving annual and multi-annual programmes and the financial contribution from the Community for the eradication, control and monitoring of certain animal diseases and zoonoses presented by the Member States for 2010 and following years approves certain national programmes and sets out the rate and maximum amount of the financial contribution by the Union for each programme submitted by the Member States.

(4) The Commission has assessed the reports submitted by the Member States on the expenditures incurred for those programmes. The results of that assessment show that certain Member States will not utilise their full allocation for the year 2010 while others will spend in excess of the allocated amount.

(5) Rabies programmes in most Member States are now approaching the stage of achieving their objective of eradicating the risk to public and animal health from that disease. It is appropriate to provide additional financial support for those programmes by increasing the rate of financing, in order to reinforce the efforts of the Member States to eradicate that disease as soon as possible.

(6) Member States have informed the Commission that the maximum limit for reimbursement per monitoring test for transmissible spongiform encephalopathies in bovine animals applied during recent years is no longer realistic. Based on the results of the Commission’s examination of that matter, it is appropriate to increase the maximum limit for reimbursement for those tests in order to approach the real costs incurred by the Member States for carrying them out.

(7) The financial contribution by the Union for a number of national programmes therefore needs to be adjusted. It is appropriate to reallocate funding from national programmes which will not use their full allocation to those that are expected to exceed it. The reallocation should be based on the most recent information on expenditure actually incurred by the concerned Member States.

(8) In addition, Portugal has submitted an amended programme for the eradication of bovine brucellosis, Spain, the Netherlands, Austria and Portugal have submitted amended programmes for the eradication and monitoring of bluetongue in endemic or high-risk areas and Bulgaria and Poland have submitted amended programmes for the eradication of rabies.

(9) The Commission has assessed those amended programmes from both the veterinary and the financial point of view. They were found to comply with relevant Union veterinary legislation and in particular with the criteria set out in the Annex to Decision 2008/341/EC. The amended programmes should therefore be approved.

(10) Decision 2009/833/EC should therefore be amended accordingly.

(11) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,

HAS ADOPTED THIS DECISION:

Article 1 Approval of the amended programme for bovine brucellosis submitted by Portugal

The amended programme for the eradication of bovine brucellosis submitted by Portugal on 25 May 2010 is hereby approved for the period from 1 January 2010 to 31 December 2010.

Article 2 Approval of amended programmes for bluetongue in endemic or high-risk areas submitted by certain Member States

The following amended programmes for the monitoring and eradication of bluetongue in endemic or high-risk areas are hereby approved for the period from 1 January 2010 to 31 December 2010:

(a) the programme submitted by Spain on 17 May 2010;

(b) the programme submitted by the Netherlands on 20 September 2010;

(d) the programme submitted by Portugal on 12 May 2010.

Article 3 Approval of amended programmes for rabies submitted by Bulgaria and Poland

The following amended programmes for the eradication of rabies are hereby approved for the period from 1 January 2010 to 31 December 2010:

(a) the programme submitted by Bulgaria on 29 September 2010;

(b) the programme submitted by Poland on 28 September 2010.

Article 4 Amendments to Decision 2009/883/EC

Decision 2009/883/EC is amended as follows:

1. in Article 1, paragraph 2 is amended as follows:

(a) in point (b), EUR 5000000 is replaced by EUR 3600000;

(b) points (e) and (f) are replaced by the following:

(e) EUR 1200000 for Portugal;

(f) EUR 1700000 for the United Kingdom.;

2. in Article 2, paragraph 2 is replaced by the following:

2. The financial contribution by the Union shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the costs of carrying out tuberculin and laboratory tests and the compensation to owners for the value of their animals slaughtered subject to those programmes, and shall not exceed:

(a) EUR 12500000 for Ireland;

(b) EUR 10100000 for Spain;

(d) EUR 1000000 for Portugal;

(e) EUR 27000000 for the United Kingdom.;

3. in Article 3(2), point (a) is replaced by the following:

(a) EUR 3000000 for Spain;;

4. in Article 4, paragraph 2 is amended as follows:

(a) in point (c), EUR 1600000 is replaced by EUR 1650000;

(b) in point (e), EUR 16800000 is replaced by EUR 1700000;

(i) EUR 19000000 for Spain;

(j) EUR 33500000 for France;;

(d) points (l) and (m) are replaced by the following:

(l) EUR 20000 for Latvia;

(m) EUR 10000 for Lithuania;;

(e) in point (o), EUR 780000 is replaced by EUR 70000;

(f) in point (q), EUR 110000 is replaced by EUR 130000;

(g) in point (t), EUR 5200000 is replaced by EUR 2100000;

(h) in point (v), EUR 590000 is replaced by EUR 40000;

(i) points (x) and (y) are replaced by the following:

(x) EUR 20000 for Finland;

(y) EUR 850000 for Sweden.;

5. in Article 5, paragraph 2 is amended as follows:

(a) in point (a), EUR 2000000 is replaced by EUR 900000;

(b) points (d) and (e) are replaced by the following:

(d) EUR 400000 for Denmark;

(e) EUR 25000 for Estonia;;

(d) in point (k), EUR 1250000 is replaced by EUR 900000;

(e) points (m) and (n) are replaced by the following:

(m) EUR 50000 for Latvia;

(n) EUR 10000 for Lithuania;;

(f) points (t) and (u) are replaced by the following:

(t) EUR 4600000 for Poland;

(u) EUR 55000 for Portugal;;

(g) points (x) and (y) are replaced by the following:

(x) EUR 600000 for Slovakia;

(y) EUR 80000 for the United Kingdom.;

6. in Article 6, paragraph 2 is amended as follows:

(a) in point (a), EUR 240000 is replaced by EUR 120000;

(b) in point (f), EUR 300000 is replaced by EUR 550000;

7. in Article 7(2), EUR 450000 is replaced by EUR 250000;

8. in Article 8, paragraph 2 is amended as follows:

(a) in point (e), EUR 350000 is replaced by EUR 450000;

(b) in point (k), EUR 650000 is replaced by EUR 1300000;

9. Article 9 is amended as follows:

(a) paragraph 2 is replaced by the following:

2. The financial contribution by the Union shall be at the rate of 100 % of the costs to be incurred by each Member State referred to in paragraph 1 for carrying out rapid tests in animals as referred to in Article 12 paragraph 2 of Regulation (EC) No 999/2001, Annex III Chapter A Parts I and II points 1 to 5 of Regulation (EC) No 999/2001 and Annex VII to that Regulation, confirmatory tests and primary molecular discriminatory tests as referred to in of Annex X Chapter C point 3(2)(c)(i) of Regulation (EC) No 999/2001 and at the rate of 50 % of the cost incurred by each Member State for the compensation to owners for the value of their animals culled and destroyed in accordance with their BSE and scrapie eradication programmes and at a rate of 50 % of the cost of the analysis of samples for genotyping, and shall not exceed:

(a) EUR 2340000 for Belgium;

(b) EUR 440000 for Bulgaria;

(d) EUR 1420000 for Denmark;

(e) EUR 11260000 for Germany;

(f) EUR 300000 for Estonia;

(g) EUR 4700000 for Ireland;

(h) EUR 2000000 for Greece;

(i) EUR 6480000 for Spain;

(j) EUR 16980000 for France;

(k) EUR 7210000 for Italy;

(l) EUR 70000 for Cyprus;

(m) EUR 360000 for Latvia;

(n) EUR 700000 for Lithuania;

(o) EUR 100000 for Luxembourg;

(p) EUR 1230000 for Hungary;

(q) EUR 30000 for Malta;

(r) EUR 3370000 for the Netherlands;

(s) EUR 1510000 for Austria;

(t) EUR 4930000 for Poland;

(u) EUR 1640000 for Portugal;

(v) EUR 1000000 for Romania;

(w) EUR 240000 for Slovenia;

(x) EUR 650000 for Slovakia;

(y) EUR 610000 for Finland;

(z) EUR 970000 for Sweden;

(za) EUR 5920000 for the United Kingdom.;

(b) in paragraph 3, in point (a), EUR 5 per test is replaced by EUR 8 per test;

10. in Article 10, paragraphs 2 and 3 are replaced by the following:

2. The financial contribution by the Union shall be at the rate of 75 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out laboratory tests for the detection of rabies antigen or antibodies, the isolation and characterisation of the rabies virus, the detection of biomarker and the titration of vaccine baits, and for the purchase and distribution of vaccine plus baits for the programmes, and shall not exceed:

(a) EUR 1870000 for Bulgaria;

(b) EUR 680000 for Hungary;

(d) EUR 820000 for Romania;

(e) EUR 490000 for Slovakia.

3. The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:

(a) for a serological test: EUR 12 per test;

(b) for a test to detect tetracycline in bone: EUR 12 per test;

11. in Article 11, paragraph 2 is amended as follows:

(a) in point (b), EUR 20000 is replaced by EUR 40000;

(b) in point (d), EUR 1400000 is replaced by EUR 650000;

12. in Article 12, paragraph 2 is replaced by the following:

2. The financial contribution by the Union to the programmes referred to in paragraph 1 shall be at the rate of 50 % of the costs to be incurred by the concerned Member State for the cost of laboratory tests, and shall not exceed:

(a) EUR 25000 for Bulgaria;

(b) EUR 300000 for Hungary;

(d) EUR 700000 for Spain.;

13. in Article 13, paragraphs 3 and 4 are replaced by the following:

3. The financial contribution by the Union shall be at the rate of 75 % of the costs to be incurred by each Member State referred to in paragraphs 1 and 2 for the cost of carrying out laboratory tests for the detection of rabies antigen or antibodies, the characterisation of the rabies virus, the detection of biomarker, age determination and the titration of vaccine baits, and for the purchase and distribution of vaccine plus baits for the programmes, and shall not exceed:

(a) EUR 1360000 for Estonia;

(b) EUR 1400000 for Latvia;

(d) EUR 200000 for Austria;

(e) EUR 830000 for Slovenia;

(f) EUR 150000 for Finland.

4. The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraphs 1 and 2 shall on average not exceed:

(a) for a serological test: EUR 12 per test;

(b) for a test to detect tetracycline in bone: EUR 12 per test;

14. in Article 14(2), EUR 262000 is replaced by EUR 310000;

15. in Article 15, paragraph 2 is amended as follows:

(a) in point (a) EUR 800000 is replaced by EUR 600000;

(b) in point (c) EUR 750000 is replaced by EUR 500000;

16. in Article 16(2), in the introductory phrase, EUR 8200000 is replaced by EUR 4000000.

Article 5 Addressees

This Decision is addressed to the Member States.

Done at Brussels, 30 November 2010. For the Commission John Dalli Member of the Commission

Versions

2010-11-30